Condition (MeSH)
Multicystic Dysplastic Kidney
ClinicalTrials.gov lists 3 trials for Multicystic Dysplastic Kidney or a narrower condition beneath it. Fetal Care Center, PLLC has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Multicystic Dysplastic Kidney itself; the rest are tagged with a narrower condition beneath it.
When did Multicystic Dysplastic Kidney trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2018 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Multicystic Dysplastic Kidney trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Not applicable | 1 |
| Expanded access | 1 |
How many Multicystic Dysplastic Kidney trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 1 |
| No longer available | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Multicystic Dysplastic Kidney trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Fetal Care Center, PLLC | 1 |
Which serious adverse events do Multicystic Dysplastic Kidney trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Fetal Loss | 4 | 1 |
| Bleeding in absence of placental abruption | 2 | 1 |
| Cardiac Disorders | 2 | 1 |
| Pregnancy, puerperium and perinatal condition | 2 | 1 |
| Premature delivery | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Multicystic Dysplastic Kidney? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Hybrid Retroperitoneoscopic Pyeloplasty for Congenital Ureteropelvic Junction Obstruction in Infants Weighing Less than 10 kg. | Journal of laparoendoscopic & advanced surgical techniques. Part A | 2021 | Yes |
| Improved split renal function after percutaneous nephrostomy in young adults with severe hydronephrosis due to ureteropelvic junction obstruction. | The Journal of urology | 2015 | Yes |
| Ultrasound diagnosis of multicystic dysplastic kidney: is a confirmatory nuclear medicine scan necessary? | Journal of pediatric urology | 2014 | Yes |
| Multicystic dysplastic kidney: is an initial voiding cystourethrogram necessary? | The Canadian journal of urology | 2014 | Yes |
| Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans. | American journal of kidney diseases : the official journal of the National Kidney Foundation | 2006 | Yes |
Showing 5 of 6 publications.
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Multicystic dysplastic kidney | Prevalence at birth | 1-5 / 10 000 | Worldwide | Not stated | Exact |
| Multicystic dysplastic kidney | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Multicystic dysplastic kidney | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Multicystic dysplastic kidney | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Multicystic dysplastic kidney | Prevalence at birth | 1-5 / 10 000 | Worldwide | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Multicystic dysplastic kidney | 1851 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Multicystic dysplastic kidney | 1851 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.